New PET tracer could light up tumors in cancer scans
NCT ID NCT01697930
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 22 times
Summary
This early-phase study tests a new radioactive drug called F-Glutamine, which is used with PET scanners to see if it can find tumors in people with solid cancers or lymphoma. Researchers want to learn how long the drug stays in the blood and where it goes in the body. If successful, this imaging method may help detect tumors better than current scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.